• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Should study subjects see their previous responses: data from a randomized control trial.

作者信息

Guyatt G H, Townsend M, Keller J L, Singer J

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

J Clin Epidemiol. 1989;42(9):913-20. doi: 10.1016/0895-4356(89)90105-4.

DOI:10.1016/0895-4356(89)90105-4
PMID:2778469
Abstract

To test the relative merits of administering questionnaires with previous responses available (the informed condition) or unavailable (the blind condition), we administered blind and informed versions of a quality of life questionnaire (the Chronic Respiratory Disease Questionnaire, or CRQ) in a randomized, double-blind trial of bronchodilators in chronic airflow limitation. The responsiveness of the two methods, as reflected in the p-values associated with salbutamol and theophylline effects were comparable for three of the four dimensions of the CRQ. The data suggested possible increased responsiveness of the informed method for the emotional function dimension of the questionnaire. Changes in the informed CRQ dyspnea and fatigue dimensions showed stronger correlations with changes in spirometry, 6 minute walk distance, and rating of dyspnea after the walk test than did blind administration. Further, changes in all four CRQ dimensions showed stronger correlations with corresponding global ratings using the informed questionnaire. These results suggest that by letting study subjects see their previous responses the validity of subjective measures of health status in clinical trials can be improved.

摘要

相似文献

1
Should study subjects see their previous responses: data from a randomized control trial.
J Clin Epidemiol. 1989;42(9):913-20. doi: 10.1016/0895-4356(89)90105-4.
2
Measuring functional status in chronic lung disease: conclusions from a randomized control trial.慢性肺病功能状态的测量:一项随机对照试验的结论
Respir Med. 1989 Jul;83(4):293-7. doi: 10.1016/s0954-6111(89)80199-4.
3
Measuring functional status in chronic lung disease: conclusions from a randomized control trial.慢性肺病功能状态的测量:一项随机对照试验的结论
Respir Med. 1991 Sep;85 Suppl B:17-21; discussion 33-7.
4
An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.在临床试验环境中对圣乔治呼吸问卷(SGRQ)和慢性呼吸道疾病问卷(CRQ)进行的实证比较。
Thorax. 1999 Nov;54(11):995-1003. doi: 10.1136/thx.54.11.995.
5
Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice.茶碱用于不可逆性慢性气流受限:一项将n-of-1试验与标准治疗方法进行比较的随机研究。
Chest. 1999 Jan;115(1):38-48. doi: 10.1378/chest.115.1.38.
6
Should study subjects see their previous responses?研究对象应该查看他们之前的回答吗?
J Chronic Dis. 1985;38(12):1003-7. doi: 10.1016/0021-9681(85)90098-0.
7
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.慢性气流受限中的支气管扩张剂。对气道功能、运动能力和生活质量的影响。
Am Rev Respir Dis. 1987 May;135(5):1069-74. doi: 10.1164/arrd.1987.135.5.1069.
8
Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.吸入用沙美特罗:其在慢性阻塞性肺疾病中疗效的综述
Drugs Aging. 2001;18(6):441-72. doi: 10.2165/00002512-200118060-00006.
9
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
Arch Intern Med. 1988 Sep;148(9):1949-52. doi: 10.1001/archinte.148.9.1949.
10
The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.茶碱对稳定期慢性阻塞性肺疾病患者吸入高剂量沙丁胺醇与异丙托溴铵联合用药的附加效应。
Chest. 1995 Mar;107(3):718-23. doi: 10.1378/chest.107.3.718.

引用本文的文献

1
Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants.FKB327 的两种生物相似性研究与阿达木单抗参比制剂的比较:健康日本男性参与者单次皮下注射、单盲、随机 1 期研究。
BMC Pharmacol Toxicol. 2022 Jan 8;23(1):6. doi: 10.1186/s40360-021-00545-3.
2
Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain.对患者至关重要的疼痛缓解:评估急性疼痛最小临床重要差异的实证研究的系统评价
BMC Med. 2017 Feb 20;15(1):35. doi: 10.1186/s12916-016-0775-3.
3
Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects.
阿达木单抗/修美乐的新型生物类似药FKB327在健康受试者中的药代动力学、安全性、耐受性及免疫原性
Br J Clin Pharmacol. 2017 Jul;83(7):1405-1415. doi: 10.1111/bcp.13245. Epub 2017 Mar 9.
4
Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.确定用于评估恶性胸腔积液患者呼吸困难的视觉模拟量表的最小重要差异。
PLoS One. 2015 Apr 15;10(4):e0123798. doi: 10.1371/journal.pone.0123798. eCollection 2015.
5
Is measured hearing aid benefit affected by seeing baseline outcome questionnaire responses?测量得到的助听器益处是否会受到查看基线结果调查问卷回复的影响?
Am J Audiol. 2011 Dec;20(2):90-9. doi: 10.1044/1059-0889(2011/10-0003). Epub 2011 Sep 22.
6
What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain.治疗开始前可接受的结果是什么?对慢性下腰痛患者的方法学考虑和启示。
Eur Spine J. 2009 Dec;18(12):1858-66. doi: 10.1007/s00586-009-1070-1. Epub 2009 Jun 23.
7
Money matters: exploiting the data from outcomes research for quality improvement initiatives.资金问题:利用结果研究数据推动质量改进举措
Eur Spine J. 2009 Aug;18 Suppl 3(Suppl 3):348-59. doi: 10.1007/s00586-009-0929-5. Epub 2009 Mar 18.
8
Health-related quality of life in emphysema.肺气肿患者与健康相关的生活质量
Proc Am Thorac Soc. 2008 May 1;5(4):561-6. doi: 10.1513/pats.200706-080ET.
9
Validation of an individualised quality of life measure in older day hospital patients.老年日间医院患者个体化生活质量测量方法的验证
Health Qual Life Outcomes. 2008 Apr 18;6:27. doi: 10.1186/1477-7525-6-27.
10
Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients.下腰痛患者疼痛和残疾评定工具的反应度及最小临床重要差异
BMC Musculoskelet Disord. 2006 Oct 25;7:82. doi: 10.1186/1471-2474-7-82.